This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-SELL monoclonal antibody, clone GND57 [PE]
catalog :
DCABH-8623
quantity :
50 Tests
clonality :
monoclonal
host :
mouse
conjugate :
PE
clone name :
GND57
reactivity :
human
application :
flow cytometry
product information
Cat :
DCABH-8623
Product Name :
Anti-SELL monoclonal antibody, clone GND57 [PE]
Brand :
Creative Diagnostics
Abbr :
Anti-SELL MAb, PE-Conjugated
Host animal :
Mouse
Clone :
GND57
Official Symbol :
SELL
Clonality :
Monoclonal
Application :
FC
Target :
SELL
Species Reactivity :
Human
Conjugate :
PE
Antibody Type :
Primary Antibodies
Immunogen :
PHA stimulated lymphoblasts (Human)
Alternative Names :
SELL; selectin L; LNHR, LYAM1, lymphocyte adhesion molecule 1; L-selectin; CD62L; hLHRc; LAM 1; LAM1; Leu 8; LSEL; Lyam 1; PLNHR; gp90-MEL; pln homing receptor; lymph node homing receptor; lymphocyte adhesion molecule 1; leukocyte surface antigen Leu-8;
UniProt ID :
A0A024R8Z0
Antibody Isotype :
IgG2b
Size :
50 Tests
Storage :
Store at +4°C in the dark. Do not freeze.
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments